Details of the Drug

General Information of Drug (ID: DM0SI61)

Drug Name
MEDI7219
Indication
Disease Entry ICD 11 Status REF
Type 2 diabetes 5A11 Phase 1 [1]
Cross-matching ID
TTD ID
D3HBL2

References

1 ClinicalTrials.gov (NCT03362593) A 6-Part Study In Healthy Volunteers To Evaluate Safety, Tolerability and Uptake Of MEDI7219 in the Body When Given as Single and Multiple Doses. U.S. National Institutes of Health.